Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Country / region: Denmark Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20151
20172
20193
20202
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Novartis Pharmaceuticals2
Dragonfly Therapeutics1
Genmab1
Henrik Ditzel1
Herlev Hospital1
Incyte Corporation1
Orion Corporation, Orion Pharma1
Pfizer1
Puma Biotechnology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms13
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms3
Bronchial Neoplasms2
Carcinoma, Bronchogenic2
Carcinoma, Medullary2
Central Nervous System Neoplasms2
Colonic Neoplasms2
Endocrine Gland Neoplasms2
Endocrine System Diseases2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.